Vol 20, No 3 (2024)

Medicine

Pediatric Immunology and Allergy: Clinical Aspects

Bernardini R.
Current Pediatric Reviews. 2024;20(3):201-202
pages 201-202 views

Why do some Children Get Sick with Recurrent Respiratory Infections?

Cardinale F., La Torre F., Tricarico L., Verriello G., Mastrorilli C.

Abstract

Respiratory tract infections (RTI) represent a frequent condition, particularly among preschool children, with an important burden on the affected children and their families. It has been estimated that recurrent RTIs affect up to 25% of children during the first 4 years of life. Th- ese infections are mainly caused by viruses and are generally self-limiting. Social and environmen- tal factors have been studied in determining the incidence of recurrent RTIs and the mostly recog- nized are precocious day care attendance, tobacco exposure and pollution. Primary immune de- fects, local anatomical factors, and genetic disorders such as primary ciliary dyskinesia or cystic fi- brosis, may be also involved in recurrent RTIs of a subgroup of children, typically characterized by more severe and chronic symptoms. However, there is increasing awareness that RTIs have a com- plex pathophysiology and that some underrecognized factors, including genetic susceptibility to in- fections, low levels of some micronutrients, and respiratory microbiota might shape the probability for the child to develop RTIs. The sum (i.e. the number) of these factors may help in explaining why some children get sick for RTIs whilst other not. In some children iatrogenic factors, includ- ing improper use of antibiotics and NSAIDS or glucocorticoids might also aggravate this condi- tion, further weakening the host's immune response and the possibly of establishing a "vicious cir- cle". The present review aims to focus on several possible factors involved in influencing RTIs and to propose a unifying hypothesis on pathophysiological mechanisms of unexplained recurrent RTIs in children.

Current Pediatric Reviews. 2024;20(3):203-215
pages 203-215 views

Acute Bronchiolitis: The Less, the Better?

Virgili F., Nenna R., Di Mattia G., Matera L., Petrarca L., Conti M.G., Midulla F.

Abstract

Background:Acute bronchiolitis is a viral infection of the lower respiratory tract affect- ing infants aged under 12 months, variably presenting with respiratory distress, diffuse crackles and inflammatory wheezing. The main causative agent is Respiratory Syncytial Virus (RSV). The diagnosis is clinical and treatment mainly supportive. Despite the availability of more than 30 in- ternational guidelines, consistent management recommendations are lacking and considerable vari- ability in patients’ care persists among different providers.

Objective:To review and describe current knowledge about epidemiology, physiopathology, clin- ic, diagnosis and management of acute bronchiolitis, with particular emphasis on updated evidence and future perspectives in terms of treatment and prevention.

Methods and Results:We searched Cochrane for systematic reviews and PubMed for scientific ar- ticles published in the last 10 years, using a combination of the following search terms: "bronchi- olitis", "respiratory syncytial virus", "epidemiology", "risk factors", "severity", "diagnosis", "clin- ic", "diagnostic imaging", "management", "asthma", "wheezing", "bronchodilator", "steroids", "hypertonic saline", "oxygen", "blood gas analysis", "HHHFNC", "rehydration", "enteral feed- ing", "parenteral hydration", "prevention", "vaccine" and "COVID-19 or SARS-CoV2". We ac- cordingly performed a deep and extensive selection of the most updated and considerable litera- ture on the matter, summarizing the most significant evidence concerning all aspects of acute bron- chiolitis (epidemiology, clinic, diagnosis, management and prevention). Furthermore, we ex- amined references and available guidelines from UK, USA, Canada, Italy and Spain. Results are extensively discussed below.

Conclusion:Although acute bronchiolitis has been a widely known disease for decades, its thera- peutic approach remained unchanged and essentially limited to respiratory and metabolic support. Despite the abundance of studies, there is no significant evidence concerning therapeutic alterna- tives (e.g. steroids, inhaled hypertonic solution), which are therefore not recommended. Accord- ing to most recent data, "acute bronchiolitis" definition encompasses a plethora of different clini- cal entities related to each subject’s genetic and immune predisposition. Therefore, future research should focus on the precise characterization of such subcategories in order to individualize thera- peutic management and ensure the most appropriate evidence-based care.

Current Pediatric Reviews. 2024;20(3):216-223
pages 216-223 views

Fish Allergy and Related Conditions in Children: A Review

Giannetti A., Bettini I., Alfieri E., De Bona A., Giannì G., Ricci G., Caffarelli C.

Abstract

Fish allergy is the important food allergies in childhood, often persisting into adulthood. It can cause severe hypersensitivity reactions, including fatal anaphylaxis; furthermore, avoiding-fish diet has negative nutritional and psychological effects. Recent research studies focus on epitope structures and aim to develop sensitive and specific diagnostic tools, which have a better correlation with clinical reactions. Protocols with hypoallergenic parvalbumin or other recombinant antigens are also under study and will likely lead to new immunotherapy protocols.

:IgE-mediated fish allergy differs substantially from other forms of immunological adverse reactions to fish, such as Food Protein-Induced Enterocolitis Syndrome and eosinophilic esophagitis. In addition, fish ingestion can cause non-immunological adverse reactions, such as in the case of scombroid poisoning, anisakiasis and toxic poisoning.

:This review aims to summarize the characteristics of the main immunological and non-immunological fish reactions, analyzing the epidemiology, clinical manifestations, diagnosis and therapy, with a particular focus on clinical management.

Current Pediatric Reviews. 2024;20(3):224-239
pages 224-239 views

Biological Therapies for Pediatric Atopic Dermatitis - A Review

Milano G., Forestieri S., Tedeschi M., Licari A., Brazzelli V., Marseglia G.

Abstract

Atopic dermatitis (AD) is the most frequent chronic-recurrent inflammatory skin disease in the pediatric age. It has a complex and multifactorial pathogenesis: the two key actors are im- paired skin barrier function and immune system dysregulation, which represent the main targets of AD therapy. Monoclonal antibodies have revolutionized the management of moderate-to-severe AD, by selective inhibition of key cytokines in the pathogenetic process. For this reason, there is great interest in exploring AD pathogenetic mechanisms to develop new therapeutic strategies. This review aims to summarize the most recent scientific evidence on available and future biologi- cal therapies for the treatment of pediatric AD, emphasizing the molecular mechanisms underlying their action.

Current Pediatric Reviews. 2024;20(3):240-252
pages 240-252 views

Hyper IgE Syndromes

Gracci S., Novelli T., D'Elios S., Bernardini R., Peroni D.

Abstract

The Hyper IgE Syndromes are rare primary immunodeficiencies characterized by eczema, recurrent skin and respiratory infections and elevated serum IgE levels. Nowadays a genetic-molecular characterization is possible and allows the distinction in various monogenic pathologies, which share some clinical characteristics but also important differences. In addition to long-known STAT3 and DOCK8 gene mutations, in fact, also ZNF341, CARD11, ERBB2IP, IL6R and IL6ST genes mutations can cause the disease. The main clinical manifestations are represented by newborn rash, eczema similar to atopic dermatitis, bacterial and viral skin infections, cold abscesses, respiratory infections with possible pulmonary complications, allergies, gastrointestinal manifestations, malignancies and connective tissue abnormalities. Diagnosis is still a challenge because, especially in the early stages of life, it is difficult to distinguish from other pathologies characterized by eczema and high IgE, such as atopic dermatitis. Several scores and diagnostic pathways have been developed, but it is essential to seek a genetic diagnosis. Treatment is based on prevention and early treatment of infections, meticulous skincare, intravenous immunoglobulins and HSCT, which, in some HIES subtypes, can modify the prognosis. Prognosis is related to the affected gene, but also to early diagnosis, timely treatment of infections and early HSCT.

Current Pediatric Reviews. 2024;20(3):253-264
pages 253-264 views

Biological Drugs for the Treatment of Uncontrolled Severe Asthma in Children

Indolfi C., Klain A., Bencivenga C., D'Addio E., Dinardo G., Decimo A., del Giudice M.

Abstract

The introduction of biological drugs for the treatment of severe allergic asthma in chil- dren, almost twenty years ago, had a substantial impact on both the pathology's clinical course and the quality of life of the patients who receive treatment. Over the years, several molecules have been developed that inhibit molecular targets involved in the pathogenesis of the asthmatic disease. Biological drugs demonstrate a significant improvement in several key clinical parameters in patients with severe asthma. In this review, we provide a concise summary of the evidence on biological therapy for children and adolescents with severe asthma.

Current Pediatric Reviews. 2024;20(3):265-270
pages 265-270 views

Treatment of Allergic Rhinitis in Clinical Practice

Tosca M., Trincianti C., Naso M., Nosratian V., Ciprandi G.

Abstract

Allergic rhinitis is a prevalent condition among children, with its occurrence reaching up to 40% of the general population in some geographical areas. A type 2 immunity sustains allergic rhinitis. Consequently, type 2 inflammation leads to eosinophilic infiltrate of the nasal mucosa. Al- lergic inflammation causes the symptom occurrence. Typical nasal symptoms include nasal itch- ing, sneezing, watery rhinorrhea, and nasal congestion. Nasal congestion depends on vasodilation and increased mucus production. These conditions result in nasal obstruction. Nasal obstruction is closely associated with type 2 inflammation. Allergic rhinitis usually occurs in association with other allergic conditions, in particular allergic conjunctivitis and asthma. The effective manage- ment of allergic rhinitis involves avoiding triggering allergens and employing pharmacological treatments as per ARIA guidelines. These treatments may include intranasal/oral antihistamines or/and nasal corticosteroids. In particular, antihistamines are particularly indicated for symptoms consequent to mediators’ release, mainly concerning histamine. These histamine-dependent symp- toms include itching, sneezing, and rhinorrhea. Nasal obstruction, being associated with inflamma- tion, is responsive to corticosteroids, administered mostly intranasally. The fixed combination of a topical antihistamine plus a topical corticosteroid is very effective, but is indicated for adolescents only. However, nasal lavage is safe, cheap, and adequate, thus its use is prevalent. Namely, nasal la- vage allows to remove secretions, allergens, mediators. In addition, hypertonic solutions exert a de- congestant activity. On the other hand, the allergen-specific immunotherapy is still the only causal treatment. Nutraceuticals have also been used to relieve symptoms. The objective of this review is to explore and compare the traditional and new therapeutic approaches for pollen-induced allergic rhinitis in children.

Current Pediatric Reviews. 2024;20(3):271-277
pages 271-277 views

Respiratory versus Cardiac Algorithm for Pediatric and Neonatal Resuscitation

Hon K., Tan Y., Leung K., Fung G., Kwok K.H., Yan Ho A., Chan B.
Current Pediatric Reviews. 2024;20(3):278-282
pages 278-282 views

Mask Wearing and Childhood COVID-19: A Local Perspective

Hon K., Tan Y., Leung K.K.
Current Pediatric Reviews. 2024;20(3):283-285
pages 283-285 views

Rectal Bleeding in Infants: Diagnostic Work-up and Management

Quitadamo P., Isoldi S., Mallardo S., Zenzeri L., Ceccanti S., Battagliere I., Del Bene M., Di Nardo G.

Abstract

Lower gastrointestinal bleeding is an alarming symptom in pediatrics, especially in in- fancy. However, it is commonly secondary to benign and self-limiting conditions, such as anal fis- sures, infections, and allergies; more rarely it is caused by more serious disorders, such as necrotiz- ing enterocolitis, very early onset inflammatory bowel diseases, and vascular malformations. The present review aims at summarizing the different clinical conditions presenting with rectal bleeding in infancy and provides an evidence-based diagnostic work-up for the clinical management of patients with this occurrence.

Current Pediatric Reviews. 2024;20(3):286-295
pages 286-295 views

Metabolic Associated Fatty Liver Disease in Children and Adolescents: Mechanisms of a Silent Epidemic and Therapeutic Options

Mosca A., Volpe L., Sartorelli M.R., Comparcola D., Veraldi S., Alisi A., Maggiore G.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is now identified as a hepatic sign of meta- bolic syndrome and is the most frequent cause of chronic liver disease in all ages. It is assumed that a genetic predisposition associated with epigenetic factors participates in the evolution of this condi- tion. Visceral obesity and insulin resistance (IR) have always been considered the most important causative factors of Metabolic Syndrome (MetS) and NAFLD, but currently, the interaction be- tween genetic heritage and environmental factors is increasingly considered fundamental in the genesis of metabolic disorders associated with NAFLD. In fact, in patients with NAFLD, insulin resistance, arterial hypertension, abdominal obesity, dyslipidemia and reduced intestinal permeability have often been found, as well as a higher prevalence of coronary artery disease, obstructive sleep apnea, polycystic ovary syndrome and osteopenia, which define a MetS framework. Early diagnosis is needed to prevent disease progression through primarily lifestyle interventions. Unfortunately, at present, there are no molecules recommended for pediatric patients. However, several new drugs are in clinical trials. For this reason, targeted studies on the interaction between genetics and envi- ronmental factors involved in the development of NAFLD and MetS and on the pathogenetic mech- anisms that determine the evolution in non-alcoholic steatohepatitis (NASH), should be implement- ed. Therefore, it is desirable that future studies may be useful in identifying patients at risk of de- veloping NAFLD and MetS early.

Current Pediatric Reviews. 2024;20(3):296-304
pages 296-304 views

Infectious Mononucleosis: An Updated Review

Leung A., Lam J., Barankin B.

Abstract

Background:Infectious mononucleosis is common among adolescents and young adults. Although the majority of cases resolve spontaneously, life-threatening manifestations, and compli- cations have been recognised.

Objective:The purpose of this article is to familiarize clinicians with the clinical manifestations, evaluation, diagnosis, and management of infectious mononucleosis.

Methods:A search was conducted in October 2022 in PubMed Clinical Queries using the key terms \"infectious mononucleosis\" OR "Epstein-Barr virus" OR "EBV". The search strategy included all clinical trials, observational studies, and reviews published within the past 10 years. Only papers published in the English literature were included in this review. The information retrieved from the aforementioned search was used in the compilation of the present article.

Results:Infectious mononucleosis, caused by Epstein-Barr virus, most commonly affects adoles- cents and adults aged 15 to 24 years. Epstein-Barr virus is transmitted primarily in saliva. Infectious mononucleosis is characterized by a triad of fever, tonsillar pharyngitis, and lymphadenopathy. Fa- tigue may be profound but tends to resolve within three months. Periorbital and/or palpebral edema, typically bilateral, occurs in one-third of patients. Splenomegaly and hepatomegaly occur in approx- imately 50% and 10% of cases, respectively. A skin rash, which is usually widely scattered, ery- thematous, and maculopapular, occurs in approximately 10 to 45% of cases. Peripheral blood leu- kocytosis is observed in most patients; lymphocytes make up at least 50% of the white blood cell differential count. Atypical lymphocytes constitute more than 10% of the total lymphocyte count. The classic test for infectious mononucleosis is the demonstration of heterophile antibodies. The monospot test is the most widely used method to detect the serum heterophile antibodies of infectious mononucleosis. When confirmation of the diagnosis of infectious mononucleosis is required in patients with mononucleosis-like illness and a negative mono-spot test, serologic testing for anti- bodies to viral capsid antigens is recommended. Infectious mononucleosis is a risk factor for chronic fatigue syndrome. Spontaneous splenic rupture occurs in 0.1 to 0.5% of patients with infectious mononucleosis and is potentially life-threatening. Treatment is mainly supportive. Reduction of activity and bed rest as tolerated are recommended. Patients should be advised to avoid contact sports or strenuous exercise for 8 weeks or while splenomegaly is still present. Most patients have an uneventful recovery.

Conclusion:Infectious mononucleosis is generally a benign and self-limited disease. Prompt diag- nosis is essential to avoid unnecessary investigations and treatments and to minimize complications. Splenic rupture is the most feared complication. As avoiding exposure to EBV is almost impossible, the most effective way to prevent EBV infection and infectious mononucleosis is the development of an effective, safe, and affordable EBV vaccine that can confer life-long immunity.

Current Pediatric Reviews. 2024;20(3):305-322
pages 305-322 views

Non-traumatic Limping in the Child: A Pediatric Rheumatologist Perspective on Etiology, Clinical Evaluation, Laboratory Diagnosis, and Diagnostic Algorithms using Musculoskeletal Ultrasound (MSUS)

Harjacek M.

Abstract

Limping refers to an asymmetrical gait that deviates from the typical gait pattern ex- pected for a child of a certain age. In most children, limping is caused by a mild, self-limiting event, such as a contusion, strain, or sprain. However, a child's limping is always a pathological finding that poses a particular diagnostic challenge and necessitates a thorough assessment. The pediatrician must weigh a wide range of acute and chronic potential causes of a non-traumatic limp, including infection, neoplasia, and chronic inflammatory disorders. A thorough history and clinical examina- tion will help us arrive at the correct diagnosis. Understanding the typical gait is essential to recog- nizing and correctly interpreting the disordered one. The examination of child limping involves us- ing a variety of diagnostic methods. Efficient and cost-effective diagnosis and treatment of the un- derlying condition requires a systematic approach. This review provides the pediatric rheumatolo- gist perspective and approach for evaluating non-traumatic limp in children, with a focus on the use of point-of-care (PoC) musculoskeletal ultrasound (MSUS) as a crucial tool in daily practice.

Current Pediatric Reviews. 2024;20(3):323-338
pages 323-338 views

Iron Deficiency Anemia: An Updated Review

Leung A., Lam J., Wong A., Hon K.L., Li X.

Abstract

Background:Worldwide, iron deficiency anemia is the most prevalent nutritional deficiency disorder and the leading cause of anemia in children, especially in developing countries. When present in early childhood, especially if severe and prolonged, iron deficiency anemia can result in neurodevelop- mental and cognitive deficits, which may not always be fully reversible even following the correction of iron deficiency anemia.

Objective:This article aimed to familiarize physicians with the clinical manifestations, diagnosis, evaluation, prevention, and management of children with iron deficiency anemia.

Methods:A PubMed search was conducted in February 2023 in Clinical Queries using the key term \"iron deficiency anemia\". The search strategy included all clinical trials (including open trials, non-randomized controlled trials, and randomized controlled trials), observational studies (including case reports and case series), and reviews (including narrative reviews, clinical guidelines, and meta-analyses) published within the past 10 years. Google, UpToDate, and Wikipedia were also searched to enrich the review. Only pa- pers published in the English literature were included in this review. The information retrieved from the search was used in the compilation of the present article.

Results:Iron deficiency anemia is most common among children aged nine months to three years and during adolescence. Iron deficiency anemia can result from increased demand for iron, inadequate iron intake, decreased iron absorption (malabsorption), increased blood loss, and rarely, defective plasma iron transport. Most children with mild iron deficiency anemia are asymptomatic. Pallor is the most frequent presenting feature. In mild to moderate iron deficiency anemia, poor appetite, fatigability, lassitude, leth- argy, exercise intolerance, irritability, and dizziness may be seen. In severe iron deficiency anemia, tachy- cardia, shortness of breath, diaphoresis, and poor capillary refilling may occur. When present in early childhood, especially if severe and prolonged, iron deficiency anemia can result in neurodevelopmental and cognitive deficits, which may not always be fully reversible even with the correction of iron deficien- cy anemia. A low hemoglobin and a peripheral blood film showing hypochromia, microcytosis, and marked anisocytosis, should arouse suspicion of iron deficiency anemia. A low serum ferritin level may confirm the diagnosis. Oral iron therapy is the first-line treatment for iron deficiency anemia. This can be achieved by oral administration of one of the ferrous preparations, which is the most cost-effective medi- cation for the treatment of iron deficiency anemia. The optimal response can be achieved with a dosage of 3 to 6 mg/kg of elemental iron per day. Parenteral iron therapy or red blood cell transfusion is usually not necessary.

Conclusion:In spite of a decline in prevalence, iron deficiency anemia remains a common cause of ane- mia in young children and adolescents, especially in developing countries; hence, its prevention is im- portant. Primary prevention can be achieved by supplementary iron or iron fortification of staple foods. The importance of dietary counseling and nutritional education cannot be overemphasized. Secondary prevention involves screening for, diagnosing, and treating iron deficiency anemia. The American Acad- emy of Pediatrics recommends universal laboratory screening for iron deficiency anemia at approximately one year of age for healthy children. Assessment of risk factors associated with iron deficiency anemia should be performed at this time. Selective laboratory screening should be performed at any age when risk factors for iron deficiency anemia have been identified.

Current Pediatric Reviews. 2024;20(3):339-356
pages 339-356 views

Distinctive Clinico-electrographic and Radiological Profile of Childhood and Adolescent Seizures

Prabha R., Bhakat R., Mohan K., Rajvanshi N., Chacham S., Mohan L.

Abstract

Aim:Electroencephalogram (EEG) is specific, but not sensitive, for the diagnosis of epi- lepsy. This study aimed to correlate the clinico-electrographic and radiological features of seizure disorders in children attending a tertiary care centre in northern India.

Methods:Children aged between one to 18 years with seizure episodes were included. Clinical de- tails, including historical as well as physical findings, were evaluated along with EEG and neuroim- aging (Magnetic resonance imaging). Details were noted on pre-designed proforma. Variables were analysed by using appropriate statistical methods.

Results:A total of 110 children with seizures were enrolled in the study. Male to female ratio was 1.6: 1, and the mean age of the study children was 8 years. The majority of the children were symp- tomatic for more than one year. The most common seizure type was Generalised Tonic Clonic Sei- zure (GTCS), and Hypoxic-ischemic Encephalopathy (HIE) sequelae was the most commonly at- tributed etiology, followed by neurocysticercosis. EEG and neuroimaging findings were found to correlate well with seizure semiology from history. The incidence of febrile seizures was 10% in this study, with nearly three-fourths of them being simple febrile seizures.

Conclusion:Microcephaly and developmental delay were the most distinctive clinical correlates in children with seizures. There was a fair agreement between the types of seizures described in histo- ry and depicted on EEG with Cohen’s kappa of 0.4. Also, there was a significant association be- tween the type of seizures on EEG and the duration of symptoms.

Current Pediatric Reviews. 2024;20(3):357-364
pages 357-364 views

Seroprevalence of ToRCH Pathogens among Children Admitted to a Tertiary Care Hospital in Eastern India for Cataract Surgery and Cochlear Transplantation

Patra A., Parija S., Parida P., Behera S., Ghosh A.

Abstract

The study aims to investigate the presence of TORCH infections in a child with bilateral cataracts and deafness and report the ToRCH-serology screening profile (Toxoplasma gondii (TOX), rubella (RV), cytomegalovirus (CMV), and herpes simplex virus (HSV-I/II)) in pediatric cataract and deafness.

Methods:Cases that had a clear clinical history of congenital cataracts and congenital deafness were included in the study. The study population consisted of 18 bilateral cataracts and 12 bilateral deafness child who was admitted to AIIMS Bhubaneswar for cataract surgery and cochlear implan- tation, respectively. Sera of all children were tested qualitatively and quantitatively for IgG/IgM-antibodies against ToRCH agents in a sequential manner.

Results:Anti-IgG antibodies against the torch panel were detected in all cataract and deafness pa- tients. Anti-CMV IgG was detected in 17 of 18 bilateral cataract children and 11 of 12 bilateral deaf children. The rates of anti-CMV IgG antibody positivity were significantly higher. In the cataract group, 94.44% and in the deafness group, 91.66% of the patient was Anti-CMV IgG positive. Be- sides this, 77.7 % of the patient from the cataract group and 75% from the deafness group was anti- RV IgG antibody positive. In bilateral cataract patients, IgG‑alone seropositive cases were mostly attributed to CMV (94.44%; 17/18), followed by RV (77.70%; 14/18), HSV‑I (27.70%; 5/18), TOX (27.70%; 5/18), and HSV‑II (16.60%; 3/18). In bilateral deafness patients, the spectrum of IgG alone seropositive cases was almost the same except for TOX (0/12).

Conclusion:The current study recommends interpreting ToRCH-screening in pediatric cataracts and deafness with caution. Interpretation should include both serial qualitative and quantitative as- says in tandem with clinical correlation to minimize diagnostic errors. The sero-clinical-positivity needs to be tested in older children who might pose a threat to the spread of infection.

Current Pediatric Reviews. 2024;20(3):365-369
pages 365-369 views

Extracorporeal Membrane Oxygenation (ECMO) in an Infant with COVID-19: A Case Report with Literature Review

Falsaperla R., Vaccalluzzo M., Collotta A., Ruggieri M., Agati S.

Abstract

Background:SARS-CoV-2 infection tends to be lethal to the elderly population. How- ever, sometimes children are also involved.

Case Presentation:We present the case of a female infant with a corrected gestational age of 39 weeks and 4 days with severe COVID-19 pneumonia and co-infection of Klebsiella pneumoniae that was supported with extracorporeal membrane oxygenation (ECMO).

Results:We reported the clinical case and reviewed the literature articles on ECMO and Covid-19 in infants and children up to two years of age

Conclusion:It is crucial to be aware of certain risk factors (severe prematurity, coinfection), which, when linked to SARS-CoV-2 infection, must immediately alert us to the possible criticality of the clinical condition of patients, as highlighted by our own clinical case

Current Pediatric Reviews. 2024;20(3):370-374
pages 370-374 views

Ovarian Torsion and Oophorectomy in Childhood: A Case Report

Shabani F., Montazeri M., Shiva S., Mirghafourvand M.

Abstract

Background:Ovarian torsion in infants can be asymptomatic or may present with ab- dominal mass and malnutrition. It is an uncommon and non-specific condition in children. We re- port a girl who underwent detorsion and ovariopexy for suspected ovarian torsion after a previous oophorectomy. The role of progesterone therapy is determined in reducing the size of adnexal mass.

Case Presentation:The patient was diagnosed with right ovarian torsion and underwent an oopho- rectomy at one year of age. About 18 months later, she was diagnosed with left ovarian torsion and underwent detorsion with lateral pelvic fixation. Despite the pelvic fixation of the ovary, a continu- ous increase in the volume of the ovarian tissue was evident during successive ultrasounds. Proges- terone therapy was started at five years of age in order to prevent retorsion and preserve the ovarian tissue. In successive follow-ups during the therapy, ovarian volume decreased, and its size (27*18 mm) was restored.

Conclusion:The presented case reminds doctors of the possibility of ovarian torsion in young girls with pelvic pain. More research is needed on the use of hormonal drugs, such as progesterone, in similar cases.

Current Pediatric Reviews. 2024;20(3):375-378
pages 375-378 views